Free Trial
LON:GWP

326553 (GWP.L) (GWP) Share Price, News & Analysis

About 326553 (GWP.L) Stock (LON:GWP)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.32 million shs
Average Volume
956,721 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using its cannabinoid technology platform.

Receive GWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 326553 (GWP.L) and its competitors with MarketBeat's FREE daily newsletter.

GWP Stock News Headlines

See More Headlines

GWP Stock Analysis - Frequently Asked Questions

Shares of GWP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that 326553 (GWP.L) investors own include GW Pharmaceuticals (GWPH), Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Immunomedics (IMMU), Alibaba Group (BABA) and Cara Therapeutics (CARA).

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
496
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (LON:GWP) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners